Literature DB >> 12186782

Phage display of recombinant antibodies toward Burkholderia pseudomallei exotoxin.

Sheila Nathan1, Hongbin Li, Rahmah Mohamed, Noor Embi.   

Abstract

We have used the phagemid pComb3H to construct recombinant phages displaying the single chain variable fragment (ScFv) towards exotoxin of Burkholderia pseudomallei. Variable heavy and light chain fragments were amplified from the hybridoma 6E6A8F3B line, with a wide spectrum of primers specific to mouse antibody genes. Through overlapping extension polymerase chain reaction, the heavy and light chain fragments were linked to form the ScFv which was subsequently cloned into the phage display vector and transformed into ER2537 cells to yield a complexity of 10(8) clones. The transformants were screened by four rounds of biopanning against the exotoxin and resulted in selective enrichment of exotoxin-binding antibodies by 301 fold. The phage pool from the final round of selection displayed antibodies of high-affinity to the exotoxin as demonstrated by ELISA. Several clones were selected randomly from this pool and analysed by restriction enzyme digestion, fingerprinting and sequencing. Restriction analysis confirmed that all clones carried a 700-800 bp insert whose sequences, in general, corresponded to that of mouse IgG. Fingerprinting profiles delineated the antibodies into two families with different CDR sequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186782     DOI: 10.1080/10258140290010232

Source DB:  PubMed          Journal:  J Biochem Mol Biol Biophys        ISSN: 1025-8140


  2 in total

1.  The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.

Authors:  Saurabh Jain; Luca Aresu; Stefano Comazzi; Jianguo Shi; Erin Worrall; John Clayton; William Humphries; Sandra Hemmington; Paul Davis; Euan Murray; Asmare A Limeneh; Kathryn Ball; Eva Ruckova; Petr Muller; Borek Vojtesek; Robin Fahraeus; David Argyle; Ted R Hupp
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

Review 2.  Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.

Authors:  Jody D Berry
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.